Comprehensive medical management of rosacea: an interim study report and literature review
- PMID: 21103305
- PMCID: PMC2989804
Comprehensive medical management of rosacea: an interim study report and literature review
Abstract
Rosacea is a common inflammatory facial dermatosis seen in adults that exhibits considerable variety in clinical presentation. Multiple medical therapeutic options are available including topical and oral treatments. Optimal medical management of rosacea includes assessment of subtype and disease severity and use of appropriate skin care to reduce epidermal barrier dysfunction. This article provides an overall discussion of the medical management of rosacea and reviews interim results from a study evaluating the role of designated skin care in rosacea treatment.
Figures
References
-
- Crawford GH, Pelle MT, James WD. Rosacea I: etiology, pathogenesis, and subtype classification. J Am Acad Dermatol. 2004;51:327–341. - PubMed
-
- Del Rosso JQ. Update on rosacea pathogenesis and correlation with medical therapeutic agents. Cutis. 2006;78:97–100. - PubMed
-
- Millikan LE. Rosacea as an inflammatory disorder: a unifying theory? Cutis. 2004;73(suppl 1):5–8. - PubMed
-
- Murphy G. Ultraviolet light and rosacea. Cutis. 2004;74(suppl 3):13–16. - PubMed
-
- Yamasaki K, et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med. 2007 Aug;13(8):975–980. - PubMed
LinkOut - more resources
Full Text Sources